Trial
NCT02987959
Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Fox Chase Cancer Center
Collaborators
—
Condition
Soft-tissue Sarcoma
Intervention
TAK-228
Why stopped
Closed to accrual due to Funding Sponsor withdrawing support due to low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-10-14